Skip to main content
Billions Co.,Ltd. logo

Billions Co.,Ltd. — Investor Relations & Filings

Ticker · 044480 ISIN · KR7044480002 KO Wholesale and retail trade
Open in API
Filings indexed 590 across all filing types
Latest filing 2020-03-04 Proxy Solicitation & In…
Country KR South Korea
Listing KO 044480

About Billions Co.,Ltd.

http://www.unidus.co.kr

Billions Co.,Ltd. is a company with diversified operations in the entertainment and manufacturing sectors. In the entertainment field, the company is involved in artist management and the production of dramas and movies. Concurrently, its manufacturing division produces and markets latex medical products, including prophylactics, surgical gloves, and finger cots. The company has previously operated under different names, including Blade Entertainment Co Ltd and Unidus Corporation, reflecting its distinct business segments.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유) filed by BioGenetics (주식회사 바이오제네틱스) for its 47th Annual General Meeting. It contains details about the solicitor, the purpose of the proxy solicitation (securing a quorum for the AGM), the date and location of the meeting, and the agenda items (financial statements approval, business overview). This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2020-03-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease in shares by a major shareholder/special related party) and provides comprehensive information about the reporting entity and its special related parties. This falls under the 'Major Shareholding Notification' category.
2020-03-02 Korean
전환가액의조정(제3회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible debt, falls under the category of Capital/Financing Update (CAP).
2020-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (BioGenetics) announcing a significant change (over 30%) in revenue or profit structure. This is a standard mandatory disclosure filing in the Korean market (DART system) used to provide preliminary financial results before the final audit is completed. Since it provides specific financial highlights and performance metrics rather than just announcing the publication of a report, it falls under the category of an Earnings Release (ER). FY 2019
2020-02-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder and their special related parties (e.g., BioGenetics Investment Fund and related entities). This type of filing is specifically used to notify the market when a shareholder crosses certain ownership thresholds or changes their holdings significantly. Since it does not fit into specific categories like 'Director's Dealing' (which is for individual insiders) or 'M&A Activity', and is a formal regulatory disclosure, it is classified as a Major Shareholding Notification.
2020-01-31 Korean
전환가액의조정(제1회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (BioGenetics) regarding the 'Adjustment of Conversion Price' for convertible bonds (CB). This type of disclosure is a standard corporate action related to capital structure and financing instruments, specifically detailing how the conversion price of debt into equity has changed due to market price fluctuations. It fits the 'Capital/Financing Update' category as it directly concerns the terms of issued financing instruments.
2020-01-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.